Ignite Creation Date:
2024-05-06 @ 9:26 AM
Last Modification Date:
2024-10-26 @ 12:14 PM
Study NCT ID:
NCT02988817
Status:
COMPLETED
Last Update Posted:
2023-08-01
First Post:
2016-12-01
Brief Title:
Enapotamab Vedotin HuMax-AXL-ADC Safety Study in Patients With Solid Tumors
Sponsor:
Genmab
Organization:
Genmab
Organization Data
Organization:
Genmab
Class:
INDUSTRY
Study ID:
GCT1021-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Genmab
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None